HOPA Now is the official podcast of the Hematology/Oncology/Pharmacy Association, an organization dedicated to supporting pharmacy practitioners and promoting the advancement of Hematology/Oncology/Pharmacy to optimize the care of individuals impacted by cancer.

 

These educational podcasts are part of our BCOP Preparatory and Recertification Course, which is designed to prepare oncology pharmacists preparing to sit for the BCOP Certification Exam, as well as meet the BPS requirement to complete a BCOP Preparatory/Recertification Review Course.

 

In this episode of HOPA Now, Dr. Lisa Holle offers an overview of genitourinary cancers, including bladder, kidney, and testicular cancers, their causes and risk factors, appropriate treatment options, and standard survival rates.

 

In this episode you will learn:

 

Genitourinary Cancers Fundamentals

• Key differences between the anatomy and pathophysiology of muscle and non-muscle invasive bladder cancers
• Survival rates of bladder cancer patients
• Various types of kidney cancers and their appropriate treatments
• The cause of early-stage prostate cancer and the inhibitors of normal growth of the prostate
• Possible mechanisms of early-stage prostate cancer
• Understanding testicular cancers as germ cell tumors, their subcategories, and common risk factors

 

Mentioned in This Episode:

HOPA

 

Quotes:

 

“Understanding the pathophysiology of bladder cancer relies on the understanding of the anatomy of the bladder.” — Dr. Lisa Holle

 

“The treatments for clear cell carcinoma are focused on targeting the pathways that are affected.” — Dr. Lisa Holle

 

“Most testicular cancers are histologically categorized as germ cell tumors.” — Dr. Lisa Holle